Education
About Us
Working with TipRanks
Follow Us
Pacific Biosciences (DE:P09)
FRANKFURT:P09
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 160.00M | $ 154.01M | $ 200.52M | $ 128.30M | $ 130.51M |
| Gross Profit | $ 50.67M | $ 37.28M | $ 52.78M | $ 49.03M | $ 58.86M |
| Operating Income | $ -557.56M | $ -474.31M | $ -334.47M | $ -307.20M | $ -210.44M |
| EBITDA | $ -34.20M | $ -242.77M | $ -271.13M | $ -282.24M | $ -250.76M |
| Net Income | $ -546.38M | $ -309.85M | $ -306.74M | $ -314.25M | $ -181.22M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 279.51M | $ 389.93M | $ 631.42M | $ 772.32M | $ 1.04B |
| Total Assets | $ 784.08M | $ 1.26B | $ 1.75B | $ 1.77B | $ 2.01B |
| Total Debt | $ 759.46M | $ 672.43M | $ 933.93M | $ 948.48M | $ 955.36M |
| Net Debt | $ 479.96M | $ 617.06M | $ 754.02M | $ 623.39M | $ 494.63M |
| Total Liabilities | $ 778.73M | $ 753.85M | $ 1.04B | $ 1.20B | $ 1.22B |
| Stockholders' Equity | $ 5.35M | $ 506.59M | $ 701.30M | $ 562.90M | $ 790.99M |
| Cash Flow | |||||
| Free Cash Flow | $ -113.92M | $ -212.25M | $ -275.39M | $ -280.14M | $ -117.11M |
| Operating Cash Flow | $ -111.21M | $ -206.06M | $ -266.55M | $ -263.21M | $ -111.18M |
| Investing Cash Flow | $ 115.45M | $ 124.00M | $ 4.60M | $ 116.08M | $ -678.53M |
| Financing Cash Flow | $ 3.43M | $ -42.99M | $ 116.27M | $ 9.62M | $ 1.17B |